Related Concept Videos
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:30Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).
bioRxiv : the preprint server for biology·2026
Same author
Alveolar Type II Cell-derived MMP1 <sup>high</sup> basal cells promote destructive microcysts in idiopathic pulmonary fibrosis.
bioRxiv : the preprint server for biology·2026
Same author
A fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosis.
The Journal of clinical investigation·2024
Related Experiment Video
Updated: Jul 19, 2026
07:52
Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis
Published on: December 21, 2014
Disorders of lung matrix remodeling.
1Department of Medicine and Cardiovascular Research Institute, University of California at San Francisco, San Francisco, California 94143-0130, USA. halchap@itsa.ucsf.edu
The Journal of Clinical Investigation
|January 15, 2004
Summary
Progressive lung fibrosis leads to respiratory failure. This review explores shared disease pathways and lung matrix remodeling in human and animal models.
Area of Science:
- Pulmonary Medicine
- Pathology
- Fibrotic Diseases
Background:
- Idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases are characterized by progressive scarring.
- These conditions ultimately result in respiratory failure, significantly impacting patient prognosis.
- Understanding the shared mechanisms underlying lung fibrosis is crucial for developing effective therapies.
Purpose of the Study:
- To review the common pathogenetic features of progressive fibrotic lung diseases.
- To highlight recent findings from human and animal studies on lung matrix remodeling.
- To identify potential therapeutic targets based on shared disease pathways.
Main Methods:
- Literature review of recent human and animal studies.
- Analysis of pathogenetic mechanisms in fibrotic lung diseases.
Main Results:
- Fibrotic lung diseases share common underlying pathogenetic pathways.
- Lung matrix remodeling is a critical process in disease progression.
- Recent research in human and animal models has elucidated key molecular mechanisms.
Conclusions:
- Shared pathways in fibrotic lung diseases offer opportunities for targeted therapies.
- Further research into lung matrix remodeling can lead to novel treatment strategies.
- A deeper understanding of commonalities can improve patient outcomes in respiratory failure.